1. Decubitus ulcer infection and bacteremia due to tazobactam/piperacillin-resistant Veillonella parvula .
- Author
-
Sahara S, Kinoshita T, Amano T, Ishida M, Yamakita T, Takimoto N, and Oka K
- Subjects
- Humans, Male, Aged, Drug Resistance, Bacterial, Gram-Negative Bacterial Infections drug therapy, Gram-Negative Bacterial Infections microbiology, Tazobactam therapeutic use, Microbial Sensitivity Tests, Piperacillin therapeutic use, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents pharmacology, Bacteremia drug therapy, Bacteremia microbiology, Piperacillin, Tazobactam Drug Combination therapeutic use, Penicillanic Acid analogs & derivatives, Penicillanic Acid therapeutic use, Pressure Ulcer microbiology, Pressure Ulcer drug therapy, Veillonella drug effects
- Abstract
This is the first case report of decubitus infection and bacteremia due to Veillonella parvula ( V. parvula ). A patient in his 70s with pre-existing diabetes mellitus was admitted with decubitus infection, and tazobactam/piperacillin treatment was initiated. Tazobactam/piperacillin-resistant V. parvula was detected in the blood and decubitus site cultures. The antimicrobial treatment was changed to clindamycin and cefmetazole. Antimicrobial therapy was administered for 28 days. The patient was transferred to a convalescent hospital. V. parvula occasionally causes infection in immunocompromised patients with underlying diseases, such as diabetes. An appropriate evaluation by culture test is important for diagnosis, treatment, and recurrence prevention. Tazobactam/piperacillin is often used in the treatment of multi-bacterial infections such as decubitus infections. V. parvula may be resistant to tazobactam/piperacillin, and this possibility should be taken into account when administering treatment., Competing Interests: None.
- Published
- 2024
- Full Text
- View/download PDF